Albendazole Medicine Price Manufacturing Analysis-NEWS-Dingzhou Kangquan Pharmaceutical - Professional Veterinary Medicine Manufacturer

Introduction

Albendazole is a broad-spectrum anthelmintic medication used to treat a variety of parasitic worm infections. Its efficacy and relatively low cost have established it as a crucial medication in both human and veterinary medicine, particularly in regions with high parasitic disease prevalence. This technical guide focuses on the pharmaceutical manufacturing aspects influencing albendazole medicine price, encompassing raw material sourcing, synthesis processes, formulation techniques, quality control parameters, and logistical considerations. The price fluctuations of albendazole are heavily influenced by the complexity of its Active Pharmaceutical Ingredient (API) production, compliance with stringent regulatory requirements (Good Manufacturing Practices - GMP), and the scalability of manufacturing processes. Understanding these factors is critical for procurement managers and pharmaceutical engineers seeking to optimize sourcing and production strategies.

Material Science & Manufacturing

The manufacturing of albendazole begins with the synthesis of its API, methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate. This process typically starts with o-phenylenediamine, undergoing reactions involving carbon disulfide, methyl iodide, and subsequent propylation. Raw material purity plays a significant role; impurities in o-phenylenediamine can lead to the formation of undesirable by-products, reducing yield and necessitating extensive purification. The particle size of the API is critically controlled during crystallization, impacting its dissolution rate and bioavailability. Techniques like anti-solvent crystallization are frequently employed to achieve the desired particle size distribution (typically between 5-20 μm). Formulation involves blending the API with excipients such as microcrystalline cellulose, lactose, sodium starch glycolate, and magnesium stearate. Manufacturing methods include wet granulation, dry granulation (slugging or roller compaction), and direct compression. Wet granulation, while often improving flowability and compressibility, necessitates careful control of moisture content to prevent API degradation. Tablet hardness, friability, and disintegration time are key process parameters monitored throughout production. The chemical stability of albendazole is susceptible to oxidation and hydrolysis, requiring packaging in airtight containers with desiccants to maintain potency.

Performance & Engineering

Albendazole’s therapeutic efficacy relies on its ability to inhibit tubulin polymerization in parasitic worms, disrupting their cellular structure and function. Formulation engineering focuses on maximizing bioavailability, which is inherently limited by the drug’s low aqueous solubility. Solid dispersion techniques, utilizing carriers like polyethylene glycol (PEG) or polyvinylpyrrolidone (PVP), are employed to enhance dissolution. The force applied during tablet compression significantly impacts tablet density and drug release kinetics. Excessive compression can lead to increased hardness but reduced dissolution rate, while insufficient compression results in friable tablets. Environmental factors such as temperature and humidity can affect albendazole’s stability. Accelerated stability studies, conducted under elevated temperature and humidity conditions (e.g., 40°C/75% RH), are essential to determine shelf life and appropriate storage conditions. Compliance with pharmacopoeial standards (USP, EP, BP) necessitates rigorous testing for assay, impurities, dissolution, and uniformity of dosage units. Bioavailability studies are crucial to confirm the therapeutic equivalence of different formulations.

Technical Specifications

Parameter	Specification (API)	Specification (Tablet Formulation)	Test Method
Assay (Albendazole Content)	≥ 99.0%	95.0 - 105.0%	HPLC
Related Substances (Impurities)	≤ 0.5% (Individual Impurity)	≤ 0.2% (Individual Impurity)	HPLC
Water Content	≤ 0.5%	≤ 2.0%	Karl Fischer Titration
Particle Size Distribution (D90)	≤ 20 μm	N/A	Laser Diffraction
Dissolution (Q60)	N/A	≥ 75.0%	USP Apparatus II
Tablet Hardness	N/A	30 - 80 N	Tablet Hardness Tester

Failure Mode & Maintenance

Common failure modes for albendazole products include tablet chipping or capping during handling, indicating insufficient binder content or improper compression force. Degradation of the API due to exposure to moisture or oxygen can lead to reduced potency and formation of degradation products. Dissolution failures, often attributed to poor particle size distribution or excipient incompatibility, can result in sub-therapeutic drug levels. Microbial contamination, particularly in non-sterile formulations, poses a significant safety risk. Preventive maintenance of manufacturing equipment, including granulation equipment, tablet presses, and coating machines, is crucial to ensure consistent product quality. Regular calibration of analytical instruments (HPLC, Karl Fischer titrator) is essential for accurate testing. Storage conditions must be carefully controlled to maintain product stability; protecting against excessive heat, humidity, and light is paramount. Comprehensive Change Control procedures must be implemented to evaluate the impact of any modifications to the manufacturing process on product quality and stability.

Industry FAQ

Q: What is the impact of API sourcing on albendazole medicine price?

A: The price of albendazole API is highly variable, dependent on the manufacturer’s location, scale of production, and the cost of raw materials (particularly o-phenylenediamine). Sourcing from manufacturers with established GMP certifications and robust quality control systems often commands a premium but minimizes the risk of quality issues and supply chain disruptions. Utilizing multiple API suppliers is a common strategy to mitigate price volatility and ensure supply security.

Q: How do formulation excipients affect the cost and performance of albendazole tablets?

A: While excipients generally represent a smaller portion of the overall cost, their selection significantly impacts tablet performance and manufacturing efficiency. Higher-grade excipients, such as microcrystalline cellulose with optimized flow properties, can reduce tablet compression issues and improve process yields. Using excipients that enhance drug solubility (e.g., solid dispersions) can improve bioavailability and potentially reduce the API dosage required.

Q: What are the key quality control tests for ensuring albendazole tablet stability?

A: Stability testing involves evaluating assay, related substances (impurities), dissolution, and physical characteristics (hardness, friability) under accelerated and long-term storage conditions. Regular monitoring of water content is critical. Analytical methods must be validated according to ICH guidelines to ensure accuracy and reliability. Data analysis should identify any degradation trends and establish appropriate retest periods or expiration dates.

Q: What role does GMP compliance play in controlling the cost of albendazole manufacturing?

A: GMP compliance, while increasing upfront investment in quality control systems and documentation, ultimately reduces long-term costs by minimizing product recalls, rework, and regulatory fines. Adhering to GMP principles ensures process consistency, reduces the risk of contamination, and builds trust with regulatory authorities, facilitating faster product approvals and market access.

Q: How can process optimization strategies reduce the overall albendazole medicine price?

A: Optimizing the manufacturing process – through techniques like Design of Experiments (DoE) to identify critical process parameters – can improve yields, reduce material waste, and minimize energy consumption. Implementing continuous manufacturing processes, where feasible, can further enhance efficiency and reduce costs compared to batch processing. Investing in automated equipment can also lower labor costs and improve process control.

Conclusion

Albendazole medicine price is a complex function of raw material sourcing, API synthesis, formulation engineering, and stringent quality control measures. Achieving cost-effectiveness requires a holistic approach that prioritizes process optimization, GMP compliance, and robust supply chain management. Understanding the interplay between these factors allows pharmaceutical manufacturers and procurement professionals to navigate market fluctuations and ensure the consistent availability of this essential medication.

Future developments in albendazole formulation, such as nanoparticle-based delivery systems, may further enhance bioavailability and reduce dosage requirements, potentially impacting manufacturing costs and overall medicine price. Continued investment in analytical technologies and process analytical technology (PAT) will be crucial for real-time monitoring and control of manufacturing processes, improving product quality and reducing variability.

Apr . 01, 2024 17:55 Back to list

Albendazole Medicine Price Manufacturing Analysis